Literature DB >> 10776821

Development of a servo-controller of heart rate using a cycle ergometer.

T Kawada1, Y Ikeda, H Takaki, M Sugimachi, O Kawaguchi, T Shishido, T Sato, W Matsuura, H Miyano, K Sunagawa.   

Abstract

In exercise training, precise control of exercise intensity would maximize the training efficacy while minimizing risks. To adjust work rate, heart rate (HR) has been used as a measure of exercise intensity. Thus, we developed a servo-controller of HR using a cycle ergometer. After estimating the transfer function from work rate to HR, we optimized feedback parameters for achieving a quick and stable HR response by means of a computer simulation. We then examined the performance of the servo-controller of HR in 55 healthy volunteers. We set the target HR at 60% and 75% of the age-predicted maximum HR. Times required for HR to reach 90% of the target HR were 136 +/- 33 and 137 +/-22s in the respective protocols. Standard deviations of the steady-state difference between the target and measured HRs were 2.5 +/- 0.6 and 3.8 +/- 1.1 beats/min. We conclude that the developed servo-controller makes it possible to precisely regulate HR and, thereby, exercise intensity.

Mesh:

Year:  1999        PMID: 10776821     DOI: 10.1007/bf02482304

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  8 in total

1.  Development of a servo-controller of heart rate using a treadmill.

Authors:  T Kawada; G Sunagawa; H Takaki; T Shishido; H Miyano; H Miyashita; T Sato; M Sugimachi; K Sunagawa
Journal:  Jpn Circ J       Date:  1999-12

2.  An overview of randomized trials of rehabilitation with exercise after myocardial infarction.

Authors:  G T O'Connor; J E Buring; S Yusuf; S Z Goldhaber; E M Olmstead; R S Paffenbarger; C H Hennekens
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

3.  Transient oxygen uptake response to exercise characterizes functional capacity of the cardiocirculatory system in patients with chronic heart failure: a random stimulus approach.

Authors:  H Takaki; K Sunagawa; M Sugimachi; Y Hara; T Kawada; T Kurita; Y Goto
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1998-09

4.  Attenuation of unfavorable remodeling by exercise training in postinfarction patients with left ventricular dysfunction: results of the Exercise in Left Ventricular Dysfunction (ELVD) trial.

Authors:  P Giannuzzi; P L Temporelli; U Corrà; M Gattone; A Giordano; L Tavazzi
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

5.  Skeletal muscle and cardiovascular adaptations to exercise conditioning in older coronary patients.

Authors:  P A Ades; M L Waldmann; W L Meyer; K A Brown; E T Poehlman; W W Pendlebury; K O Leslie; P R Gray; R R Lew; M M LeWinter
Journal:  Circulation       Date:  1996-08-01       Impact factor: 29.690

6.  Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials.

Authors:  N B Oldridge; G H Guyatt; M E Fischer; A A Rimm
Journal:  JAMA       Date:  1988-08-19       Impact factor: 56.272

7.  Exercise conditioning in older coronary patients. Submaximal lactate response and endurance capacity.

Authors:  P A Ades; M L Waldmann; E T Poehlman; P Gray; E D Horton; E S Horton; M M LeWinter
Journal:  Circulation       Date:  1993-08       Impact factor: 29.690

8.  Management of heart failure. II. Counseling, education, and lifestyle modifications.

Authors:  K Dracup; D W Baker; S B Dunbar; R A Dacey; N H Brooks; J C Johnson; C Oken; B M Massie
Journal:  JAMA       Date:  1994-11-09       Impact factor: 56.272

  8 in total
  2 in total

1.  Heart rate regulation during cycle-ergometer exercise via event-driven biofeedback.

Authors:  Ahmadreza Argha; Steven W Su; Branko G Celler
Journal:  Med Biol Eng Comput       Date:  2016-06-03       Impact factor: 2.602

2.  Robust control of heart rate for cycle ergometer exercise.

Authors:  Kenneth J Hunt; Cédric C Hurni
Journal:  Med Biol Eng Comput       Date:  2019-08-30       Impact factor: 2.602

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.